| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Borgeson Blake is a Director at RECURSION PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $21.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 220,000 | $4.36 | $959,200.00 | -3.2% | -30.8% | - | |
| Dec 2, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 220,000 | $4.37 | $961,400.00 | -3.1% | -16.0% | - | |
| Nov 12, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 11,447 | $7.64 | $87,457.37 | -0.2% | +0.9% | -38.7% | |
| Oct 29, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 11,447 | $6.72 | $76,926.13 | -0.2% | +4.3% | -12.9% | |
| Oct 15, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 11,447 | $6.67 | $76,326.31 | -0.2% | +1.0% | +1.8% | |
| Oct 1, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 11,447 | $6.22 | $71,149.97 | -0.2% | +9.7% | -17.3% | |
| Sep 17, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 11,447 | $6.84 | $78,332.97 | -0.2% | +10.1% | -30.3% | |
| Sep 3, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 11,447 | $6.27 | $71,717.74 | -0.2% | +24.9% | -23.7% | |
| Aug 20, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 11,447 | $7.12 | $81,532.40 | -0.2% | -14.8% | -33.4% | |
| Aug 6, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 11,447 | $6.82 | $78,083.42 | -0.2% | -1.0% | -18.3% |